reneta pharma

Upload: rm1912

Post on 03-Apr-2018

221 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/28/2019 Reneta Pharma

    1/26

    Particulars 2008 2009 2010 2011

    Turnover 3089746417 3900732314 5090318113 6519639234

    cost of sales 1526514685 1820496777 2405361976 3099355955

    Gross profit 1563231732 2080235537 2684956137 3420283279

    Less:operating expense 845169923 1118768795 1378630620 1702913272

    Operating profit 718061809 961466742 1306325517 1717370007

    Plus: other income 15420344 8050515 5992117 21477196Plus:gain on disposal of asset 118000 930500 593908 -3518170

    Less: interest expense 87270665 99513638 117473675 215315416

    Less:other expense 5,913,520 6,752,520 8,195,771 9,234,832

    Less: Contribution to WPPF 30496000 41151504 56480177 71941847

    Profit before tax 609919968 823030095 1130761919 1438836938

    Tax expense 176774164 219505643 278175022 351117807

    Net income 433145804 603524452 852586897 1087719131

    less: Dividend 86759000 122909000 153636000 192045000

    Transfer to the retained earning 346386804 480615452 698950897 895674131

    Depreciation 304330750.2 418890260.1 769371686.4 1134854810

  • 7/28/2019 Reneta Pharma

    2/26

    2012

    7671572303

    3619613644

    4051958659

    1880513705

    2171444954

    7995455-218312

    370881897

    10,345,556

    85618793

    1712375851

    474449485

    1237926366

    240056000

    997870366

    1280677908

  • 7/28/2019 Reneta Pharma

    3/26

    Particulars 2008 2009

    Non current asset

    Property, plant and equipment 1014435834 1396300867

    Capital work-in-progress 570277998 736960533

    Investment in subsidiary 63070376 63070376

    Other investment 8377754 11931079

    Total non-current assets 1656161962 2208262855

    Current asset

    Inventories 959414590 1075310581

    Trade and other receivables 344226933 343870341

    Advances, deposits and prepayments 79,281,411 80,677,337

    Cash and cash equivalents 123148038 143248172

    Total current assets 1506070972 1643106431

    Total assets 3162232934 3851369286

    EQUITY AND LIABILITIES

    Share capital 115678700 144598400

    Revaluation surplus 155075461 154596958

    Tax holiday reserve 52862514 83346636

    Retained earnings 1338456682 1824737962

    Total equity attributable to equity holders of the company 1662073357 2207279956

    Non-current liabilities

    Deferred liability-staff gratuity 105224160 124183595

    Deferred tax liabilities 81542581 110179135

    Long term loan

    Non-convertible BondTotal non-current liabilities 186766741 234362730

    Current liabilities

    Bank overdraft 823163615 794424620

    Creditors for goods 127107689 27896925

    Accrued expenses 133013604 171928847

    Other payables 79902838 237310646

    Unclaimed dividend 3173467 3961604

    Provision for taxation 147031623 174203958

    Total current liabilities 1313392836 1409726600

    Total liabilities 1500159577 1644089330

    Total equity and liabilities 3162232934 3851369286

    No. of outstanding share

  • 7/28/2019 Reneta Pharma

    4/26

    2010 2011 2012

    2564572288 3782849367 4268926361

    363998451 1370222641 2061905242

    63070376 63070376 63070376

    58965084 11333863 48955276

    3050606199 5227476247 6442857255

    1303637035 1585100179 1986744883

    488934817 640195291 843231267

    110721962 97,564,211 148951592

    178384225 141265972 331292974

    2081678039 2464125653 3310220716

    5132284238 7691601900 9753077971

    180748000 225935000 282418750

    154118455 158434421 157955917

    124166310 131443579 206609359

    2512438179 3442795036 4423495722

    2971470944 3958608036 5070479748

    138540457 149138826 175366283

    152716016 198004754 272041423

    358333333

    1000000000291256473 347143580 1805741039

    1129414884 2402992758 1812605178

    31752362 50168661 41207200

    220862988 326941029 272566530

    297285203 343920388 340461110

    5164759 6551459 7907075

    185076625 255275989 402110091

    1869556821 3385850284 2876857184

    2160813294 3732993864 4682598223

    5132284238 7691601900 9753077971

    28241875

  • 7/28/2019 Reneta Pharma

    5/26

    particular 2008 2009

    Sales growth rate 0.262476523

    Average sales growth rate

    COGS in proportion to sales 0.494058243 0.466706411

    Average proportion

    Operating expense in proportion to sales 0.273540223 0.286809938

    Average proportion

    Growth rate of other income -0.477928962

    Average proportion

    Growth rate of other expense 0.141878272

    Average

    Total loan 823163615 794424620

    Average loan 808794117.5

    Interest rate 0.123039518

    Average interest rate

    Short-term loan in proportion to sales 0.266417856 0.203660379

    Average proportion

    Proportion of contribution to WPPF to sales 0.009870066 0.010549687

    Average proportion

    Gain (loss) on sale of an equipment growth 6.88559322

    average rate

    tax rate 0.289831737 0.266704273

    average

    Growth rate of PPE 0.376430938

    Average growth rate

    Other investments growth rate 0.42413814

    average rate

    Normalized rate

    Inventory in proportion to sales 0.310515641 0.275668899

  • 7/28/2019 Reneta Pharma

    6/26

    Avg. Proportion

    Trade and other receivables proportion to sales 0.111409445 0.088155329

    average proportion

    Advances, deposits and prepayments 0.02565952 0.020682613

    average

    Cash and cash equivalents 0.039857005 0.036723405

    average

    Grwth rate of Capital work-in-progress 0.292282949

    averaage

    creditors in proportion to sales 0.04113855 0.007151715

    average

    Accrued expenses 0.043050007 0.044076043

    average

    Other payables 0.025860646 0.06083746

    average

    Growth rate for unclaimed dividends 0.248352039

    average

    Tax 0.18480606

    average

    Growth rate of deffered liability(staff gratuity) 0.180181386

    average

    Growth rate Deferred tax liabilities 0.351185278

    average

  • 7/28/2019 Reneta Pharma

    7/26

    unclaimed dividend to divedend 0.248352039

    average

    growth rate of depreciation

    Dividend payout ratio 0.200299759 0.203652063

    average

    Tax holiday reserve in proportion to net income 0.122043232 0.13809985

    average rate

    Growth of revaluation of surplus -0.003085614

    Average Rate

    Depreciation in proportion to PPE 0.3 0.3

    Average Rate

  • 7/28/2019 Reneta Pharma

    8/26

  • 7/28/2019 Reneta Pharma

    9/26

    0.268877547 0.268877547 0.268877547 0.268877547

    0.096051918 0.098194895 0.109916355

    0.100745588 0.100745588 0.100745588 0.100745588

    0.021751482 0.014964664 0.019416045

    0.020494865 0.020494865 0.020494865 0.020494865

    0.035043827 0.021667759 0.043184495

    0.035295298 0.035295298 0.035295298 0.035295298

    -0.506081486 2.764363934 0.504795776

    0.763840293 0.763840293 0.763840293 0.763840293

    0.006237795 0.007695006 0.005371415

    0.013518896 0.013518896 0.013518896 0.013518896

    0.043388838 0.050147104 0.035529422

    0.043238283 0.043238283 0.043238283 0.043238283

    0.058402087 0.052751445 0.044379574

    0.048446242 0.048446242 0.048446242 0.048446242

    0.303704005 0.268492683 0.206918184

    0.256866728 0.256866728 0.256866728 0.256866728

    0.062413433 0.37929892 0.575197466

    0.30042897 0.30042897 0.30042897 0.30042897

    0.115609972 0.076500174 0.373913593

    0.186551281 0.186551281 0.186551281 0.186551281

    0.386070203 0.296555261 0.373913593

    0.351931084 0.351931084 0.351931084 0.351931084

  • 7/28/2019 Reneta Pharma

    10/26

    0.303704005 0.268492683 0.206918184

    0.256866728 0.256866728 0.256866728 0.256866728

    0.180199814 0.176557527 0.193917834

    0.190925399 0.190925399 0.190925399 0.190925399

    0.145634786 0.120843309 0.166899555

    0.138704146 0.138704146 0.138704146 0.138704146

    -0.003095164 0.028004213 -0.003020202

    0.004700808 0.004700808 0.004700808 0.004700808

    0.3 0.3 0.3

    0.3 0.3 0.3 0.3

  • 7/28/2019 Reneta Pharma

    11/26

    Time Monthly Closing- Renata limited

    12/31/2012 739.5

    11/29/2012 764.5

    10/31/2012 830

    9/30/2012 848.4

    8/30/2012 869.5

    7/30/2012 856.7

    6/28/2012 905.5

    5/31/2012 880.2

    31-04-12 1214.2

    3/29/2012 1179.1

    2/29/2012 1016

    1/28/2012 1013.5

    12/31/2011 1205

    11/30/2011 12696

    10/31/2011 12662.5

    9/29/2011 13229

    8/25/2011 11782

    7/31/2011 11536

    6/30/2011 10695.25

    5/31/2011 10656.254/28/2011 12427.25

    3/30/2011 12721.75

    2/28/2011 10474.5

    1/31/2011 12417.75

    12/30/2010 12942.8

    11/30/2010 12997.5

    10/31/2010 12315

    9/30/2010 11012

    8/31/2010 11149

    7/29/2010 11258

    6/30/2010 10469

    5/31/2010 12472

    4/29/2010 12590

    3/31/2010 12290

    2/28/2010 11861

    1/31/2010 13222

    12/30/2009 12051.5

    11/26/2009 10016.8

    10/29/2009 8981.25

  • 7/28/2019 Reneta Pharma

    12/26

    9/30/2009 7998.5

    8/31/2009 7423.5

    7/30/2009 6732.75

    6/30/2009 6944.5

    5/31/2009 6602.5

    4/30/2009 8051.5

    3/31/2009 80042/26/2009 7889

    1/29/2009 7865.5

    12/30/2008 7789.25

    11/30/2008 7587

    10/30/2008 7544.75

    9/25/2008 7835.25

    8/31/2008 7309

    7/31/2008 7174.5

    6/30/2008 7401.5

    5/29/2008 8133.25

    4/30/2008 8848

    3/31/2008 8982.25

    2/28/2008 7143.25

    1/31/2008 6736.25

    12/30/2007 7491.25

    11/29/2007 5947

    10/31/2007 5304.25

    9/30/2007 5069

    8/29/2007 4860.5

    7/31/2007 4808.75

    6/28/2007 38575/31/2007 3591.25

    4/30/2007 3561.5

    3/29/2007 3265

    2/27/2007 3200

    1/28/2007 3500.5

    covarience

    Variance of market return

    Beta

    market return

    market return yearly

  • 7/28/2019 Reneta Pharma

    13/26

    DSE General Index Renata Limited Return DSE General Return

    4219.31416 -0.032701112 0.00

    4210.58149 -0.078915663 -0.06

    4493.92049 -0.021687883 -0.01

    4544.40647 -0.02426682 0.02

    4446.8703 0.014941053 0.07

    4159.16692 -0.053892877 -0.09

    4572.87836 0.028743467 -0.03

    4734.33314 -0.275078241 -0.07

    5098.90404 0.029768467 0.02

    4990.32474 0.160531496 0.06

    4695.40854 0.0024667 0.13

    4153.96414 -0.158921162 -0.21

    5257.60585 -0.905088217 0.00

    5268.554 0.002645607 0.05

    5036.498 -0.042822587 -0.15

    5910.203 0.122814463 -0.05

    6211.997 0.021324549 -0.04

    6459.623 0.078609663 0.06

    6117.234 0.003659824 0.06

    5758.264 -0.142509405 -0.056050.846 -0.023149331 -0.03

    6249.35375 0.214544847 0.20

    5203.085 -0.156489702 -0.30

    7484.228 -0.040566956 -0.10

    8290.413 -0.004208502 -0.04

    8602.441 0.055420219 0.08

    7957.121 0.118325463 0.12

    7097.382 -0.012288098 0.07

    6657.975 -0.009682004 0.05

    6342.758 0.075365364 0.03

    6153.677 -0.160599743 0.01

    6107.814 -0.009372518 0.08

    5654.877 0.02441009 0.01

    5582.334 0.036168957 0.00

    5560.561 -0.102934503 0.04

    5367.107 0.097124839 0.18

    4535.532 0.203128744 0.04

    4380.948 0.115301322 0.30

    3364.262 0.122866788 0.09

  • 7/28/2019 Reneta Pharma

    14/26

    3083.886 0.077456725 0.05

    2941.284 0.102595522 0.01

    2914.534 -0.030491756 -0.03

    3010.264 0.051798561 0.17

    2572.18 -0.179966466 0.01

    2554.355 0.005934533 0.04

    2446.922 0.014577259 -0.052570.964 0.002987731 -0.03

    2649.494 0.009789132 -0.05

    2795.336 0.02665744 0.13

    2468.918 0.00559992 -0.10

    2748.598 -0.037076035 -0.07

    2966.818 0.072000274 0.06

    2791.21 0.018746951 0.01

    2761.049 -0.030669459 -0.08

    3000.498 -0.089970184 -0.05

    3167.993 -0.080780967 0.03

    3072.851 -0.014946144 0.02

    3016.49 0.25744584 0.03

    2931.384 0.060419373 0.01

    2907.167 -0.100784248 -0.04

    3017.213 0.259668741 0.02

    2971.112 0.121176415 0.04

    2850.814 0.046409548 0.12

    2548.187 0.042896821 0.04

    2455.087 0.010761632 0.03

    2384.182 0.246759139 0.11

    2149.317 0.073999304 0.072003.585 0.008353222 0.15

    1743.328 0.090811639 -0.01

    1760.876 0.0203125 -0.02

    1797.66681 -0.085844879 0.01

    1780.52181

    0.004938797

    0.008186459

    0.603288538

    0.02

    0.20

  • 7/28/2019 Reneta Pharma

    15/26

    Particulars 2012 2013 2014

    Turnover 7671572303 9637259251 12106614160

    cost of sales 3619613644 4588319537 5763984638

    Gross profit 4051958659 5048939714 6342629522

    Less:operating expense 1880513705 2577984315 3238541229

    Operating profit 2171444954 2470955399 3104088293

    Plus: other income 7995455 10439873.53 13631614.37Plus:gain on disposal of asset -218312 -291329.1265 -388767.7267

    Less: interest expense 370881897 482377471.9 562458313.7

    Less:other expense 10,345,556 11904292.67 13697879.94

    Less: Contribution to WPPF 85618793 103524449.9 130050519.3

    Profit before tax 1712375851 1883297729 2411124427

    Tax expense 474449485 498562587 638293358.3

    Net income 1237926366 1384735142 1772831069

    Dividend 240056000 264381110.1 338478480

    Transfer to retained earnings 997870366 1120354032 1434352589

    Depreciation 1280677908 1862316105 2708113611

  • 7/28/2019 Reneta Pharma

    16/26

    2015

    15208691870

    7240890405

    7967801466

    4068352638

    3899448827

    17799153.4-518795.8621

    663058269.4

    15761702.11

    163373363.5

    3074535850

    813917270.7

    2260618579

    431609505.3

    1829009074

    3938042157

  • 7/28/2019 Reneta Pharma

    17/26

    Particulars 2012

    Non current asset

    Property, plant and equipment 4268926361

    Capital work-in-progress 2061905242

    Investment in subsidiary 63070376

    Other investment 48955276

    Total non-current assets 6442857255

    Current asset

    Inventories 1986744883

    Trade and other receivables 843231267

    Advances, deposits and prepayments 148951592

    Cash and cash equivalents 331292974

    Total current assets 3310220716

    Total assets 9753077971

    EQUITY AND LIABILITIES

    Share capital 282418750

    Revaluation surplus 157955917

    Tax holiday reserve 206609359

    Retained earnings 4423495722

    Total equity attributable to equity holders of the company 5070479748

    Non-current liabilities

    Deferred liability-staff gratuity 175366283

    Deferred tax liabilities 272041423

    Long term loan 358333333

    Non-convertible Bond 1000000000

    Total non-current liabilities 1805741039Current liabilities

    Bank overdraft 1812605178

    Creditors for goods 41207200

    Accrued expenses 272566530

    Other payables 340461110

    Unclaimed dividend 7907075

    Provision for taxation 402110091

    Total current liabilities 2876857184

    Total liabilities 4682598223

    Total equity and liabilities 9753077971

  • 7/28/2019 Reneta Pharma

    18/26

    2013 2014 2015

    6207720350 9027045371 13126807191

    3636871546 6414860574 11314789555

    63070376 63070376 63070376

    85671733 149925532.8 262369682.3

    9993334006 15654901854 24767036805

    2591242627 3255196717 4089275762

    970911354.3 1219687968 1532208612

    197514325.7 248123420.7 311700084.1

    0 0 0

    3759668307 4723008106 5933184459

    13753002312 20377909960 30700221263

    353023437.5 441279296.9 551599121.1

    158698437.4 159444448.3 160193966.1

    192068505.6 245899019.7 313557169.9

    5421366088 6541720120 7976072708

    6125156468 7388342885 9001422966

    208081087.8 246898881.3 292958184

    367781255.8 497214911.8 672200294.6

    358333333 358333333 358333333

    1000000000 1000000000 1000000000

    1934195677 2102447126 2323491812

    2499532061 3139987154 3944546053

    130285108.2 163668061.1 205604727.9

    416698542 523469208.2 657597721.8

    466888997.2 586519963.6 736803972.1

    9938139.481 12490916.85 15699417.78

    522915611.4 680014609.8 884310698.4

    4046258460 5106149914 6444562591

    5980454136 7208597040 8768054403

    12105610605 14596939924 17769477368

  • 7/28/2019 Reneta Pharma

    19/26

    Risk free rate 0.085

    Market return 0.20

    Beta 0.603288538

    Cost of equity 0.151934741

    Cost of debt 0.125037403After tax cost of debt 0.091936439

    Total market value of equity 20884866563

    Book value of debt 3170938511

    Weight of equity 0.868184062

    Weight of debt 0.131815938

    WACC 0.144026009

  • 7/28/2019 Reneta Pharma

    20/26

    Particulars 2012 2013 2014

    Inventory 1986744883 2591242627 3255196717

    Trade and other receivables 843231267 970911354.3 1219687968

    Advanced deposits and repayments 148951592 197514325.7 248123420.7

    Non-cash current asset 2978927742 3759668307 4723008106

    Creditors 41207200 130285108.2 163668061.1

    Accrued Expense 272566530 416698542 523469208.2

    Others 340461110 466888997.2 586519963.6

    Unclaimed dividends 7907075 9938139.481 12490916.85

    Provision For Taxation 402110091 522915611.4 680014609.8

    Non- STD Current liabilities 1064252006 1546726398 1966162760

    Working capital 1914675736 2212941908 2756845346

    Change in WC 298266172.4 543903437.8

  • 7/28/2019 Reneta Pharma

    21/26

    2015

    4089275762

    1532208612

    311700084.1

    5933184459

    205604727.9

    657597721.8

    736803972.1

    15699417.78

    884310698.4

    2500016538

    3433167920

    676322574.2

  • 7/28/2019 Reneta Pharma

    22/26

    Particulars 2013 2014

    EBIT 1712375851 1883297729

    EBIT (1-tax rate) 1259061157 1384735142

    Depreciation 1862316105 2708113611Less:Capital expenditure 1938793989 2819325021

    Less: Change in NWC 298266172.4 543903437.8

    Free cashflow 884317100.1 729620294.5

    Present value discount factor 0.874106001 0.764061302

    Present value of free cashflow 772986884.3 557474632

    Terminal value

    Enterprise value 7089221144

    ADD:Cash 331292974

    Less:Interest-bearing debt 3170938511

    Equity value 10591452629

    Value per share 375.0265387

  • 7/28/2019 Reneta Pharma

    23/26

  • 7/28/2019 Reneta Pharma

    24/26

    Particulars 2008 2009Sales 3089746417 3900732314

    Net Profit after Tax 433145804 603524452

    OCF 217478117 751083736

    Earnings per share 37.44386858 41.7379758

    NAV per share 73.56 97.7

    OCF per share 18.80018681 51.94274183

    No of outstanding share 11567870 14459840

    Sales Per Share 267.0972631 269.7631726

    Market price 778.92 1205.15

    Price/ EPS 20.80233773 28.87418417

    Price/SPS 2.916241039 4.467437079

    Price/OCFPS 41.4315032 23.20150915

    Price/NAVPS 10.58890701 12.33520983

  • 7/28/2019 Reneta Pharma

    25/26

    2010 2011 2012 Average5090318113 6519639234 7671572303

    852586897 1087719131 1237926366

    786059727 900132824 1087259497

    47.16992149 48.14301153 43.83300918

    131.52 175.21 179.54

    43.48926279 39.84034452 38.49813431

    18074800 22593500 28241875

    281.6251418 288.5626058 271.6382076

    1294.27 1205 739.5

    27.43845991 25.02959332 16.8708472 23.80308447

    4.595718947 4.175870247 2.722371078 3.775527678

    29.76067924 30.24572238 19.20872305 28.7696274

    9.840860706 6.877461332 4.118859307 8.752259637

  • 7/28/2019 Reneta Pharma

    26/26

    Assumption

    1.Perpetual growth rate is 2percent

    2.Risk free rate 8.5 percent

    3. Cash is zero for the year of 2013,2014 and 2014